Skip to content
2000
image of Phytochemicals in Cancer Therapy: Unleashing the Healing Power of Herbs

Abstract

Introduction

Cancer is a complex disease caused by genetic mutations and external factors like radiation and lifestyle choices. Traditional treatments, including chemotherapy and radiation, often cause severe side effects, prompting interest in alternative therapies. Herbal remedies, rich in phytochemicals, have shown promise in cancer prevention and treatment by targeting tumor growth, inducing apoptosis, and inhibiting angiogenesis and metastasis. This review article aims to explore and analyze the potential of herbal remedies in cancer treatment, focusing on their mechanisms of action, including apoptosis induction, inhibition of angiogenesis, and modulation of molecular pathways.

Methods

This review examines key phytochemicals curcumin, naringenin, capsaicin, and resveratrol for their anticancer properties. Relevant studies were analyzed to assess their mechanisms of action, such as apoptosis induction, inhibition of molecular pathways like COX-2 and 5-LOX, and protective effects on healthy cells. A literature search was conducted using databases such as PubMed, Scopus, and Web of Science. Keywords included “phytochemicals,” “herbal,” “curcumin,” “naringenin,” “capsaicin,” “resveratrol,” “herbal remedies,” and “cancer therapy.” Studies published in peer reviewed journals over the past 30 years were selected. The quality of the literature was assessed based on study design, sample size, reproducibility, and relevance to cancer treatment.

Results

The findings highlight that these phytochemicals exert significant anti-cancer effects by inducing cell cycle arrest and apoptosis while inhibiting angiogenesis and metastasis. For example, curcumin and resveratrol inhibit cancer progression by targeting key molecular pathways. Additionally, herbal remedies protect healthy cells from damage often caused by chemotherapy and radiation, making them an attractive alternative or complementary option for treatment.

Discussion

These phytochemicals demonstrated significant therapeutic potential through multi-targeted actions, such as apoptosis induction, angiogenesis inhibition, and protection of healthy cells. Their ability to complement conventional therapies, highlights the relevance of integrating herbal remedies into cancer management strategies.

Conclusion

Herbal remedies, with their potent phytochemicals, offer a promising alternative to cancer therapy, providing protective effects to normal cells while targeting cancerous ones. Their lower toxicity compared to conventional treatments suggests they could play a crucial role in future cancer therapies. However, further clinical research is needed to establish optimal dosages and treatment protocols for effective integration into cancer care.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947366002250409170920
2025-04-24
2025-09-08

  • From This Site

    /content/journals/cctr/10.2174/0115733947366002250409170920
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Kamal N. Ilowefah M.A. Hilles A.R. Anua N.A. Awin T. Alshwyeh H.A. Aldosary S.K. Jambocus N.G.S. Alosaimi A.A. Rahman A. Mahmood S. Mediani A. Genesis and mechanism of some cancer types and an overview on the role of diet and nutrition in cancer prevention. Molecules 2022 27 6 1794 10.3390/molecules27061794 35335158
    [Google Scholar]
  2. Gupta C. Prakash D. Phytonutrients as therapeutic agents. J. Complement. Integr. Med. 2014 11 3 151 169 10.1515/jcim‑2013‑0021 25051278
    [Google Scholar]
  3. Moorthy B. Chu C. Carlin D.J. Polycyclic aromatic hydrocarbons: From metabolism to lung cancer. Toxicol. Sci. 2015 145 1 5 15 10.1093/toxsci/kfv040 25911656
    [Google Scholar]
  4. Ho J. Leung Y. Chan C. Herbal medicine in the treatment of cancer. Curr. Med. Chem. Anticancer Agents 2002 2 2 209 214 10.2174/1568011023354164 12678744
    [Google Scholar]
  5. Korrapati S. Kurra P. Puttugunta S. Natural and herbal remedies for cancer treatment. Inventi Impact: Planta Activa. 2016 2016 2249 3557
    [Google Scholar]
  6. Sri P.U. Sree N.V. Revathi S. Kumar Y.A. Sri N.D. Role of herbal medicines in cancer. Int. J. Pharm. Sci. Res. 2010 1 11 7
    [Google Scholar]
  7. Sharma S.S. Kochupillai V. Gupta S.K. Seth S.D. Gupta Y.K. Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs. J. Ethnopharmacol. 1997 57 2 93 96 10.1016/S0378‑8741(97)00054‑8 9254112
    [Google Scholar]
  8. Prakash J. Gupta S.K. Chemopreventive activity of Ocimum sanctum seed oil. J. Ethnopharmacol. 2000 72 1-2 29 34 10.1016/S0378‑8741(00)00194‑X 10967450
    [Google Scholar]
  9. Johariya V. Joshi A. Malviya N. Malviya S. Introduction to Cancer. InMedicinal Plants and Cancer Chemoprevention. Boca Raton, FL CRC Press 2024 1 28
    [Google Scholar]
  10. Matthews H.K. Bertoli C. Bruin D.R.A.M. Cell cycle control in cancer. Nat. Rev. Mol. Cell Biol. 2022 23 1 74 88 10.1038/s41580‑021‑00404‑3 34508254
    [Google Scholar]
  11. Jiang WG Sanders AJ Katoh M Ungefroren H Gieseler F Prince M Thompson SK Zollo M Spano D Dhawan P Sliva D Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Seminars In cancer Biology United States Academic Press 2015 35 S244 S275
    [Google Scholar]
  12. Egeblad M. Nakasone E.S. Werb Z. Tumors as organs: Complex tissues that interface with the entire organism. Dev. Cell 2010 18 6 884 901 10.1016/j.devcel.2010.05.012 20627072
    [Google Scholar]
  13. Anand U. Dey A. Chandel A.K.S. Sanyal R. Mishra A. Pandey D.K. Falco D.V. Upadhyay A. Kandimalla R. Chaudhary A. Dhanjal J.K. Dewanjee S. Vallamkondu J. Lastra P.D.L.J.M. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023 10 4 1367 1401 10.1016/j.gendis.2022.02.007 37397557
    [Google Scholar]
  14. Ben-Arye E. Ali-Shtayeh M.S. Nejmi M. Schiff E. Hassan E. Mutafoglu K. Afifi F.U. Jamous R.M. Lev E. Silbermman M. Integrative oncology research in the Middle East: Weaving traditional and complementary medicine in supportive care. Support. Care Cancer 2012 20 3 557 564 10.1007/s00520‑011‑1121‑0 21360035
    [Google Scholar]
  15. Zaid H Silbermann M Ben-Arye E Saad B. Greco-Arab and Islamic herbal-derived anticancer modalities: From tradition to molecular mechanisms. Evid. Based Complement. Alternat. Med. 2012 2012 349040 10.1155/2012/349040
    [Google Scholar]
  16. Hosseini M.M. Karimi A. Behroozaghdam M. Javidi M.A. Ghiasvand S. Bereimipour A. Aryan H. Nassiri F. Jangholi E. Cytotoxic and apoptogenic effects of cyanidin-3-glucoside on the glioblastoma cell line. World Neurosurg. 2017 108 94 100 10.1016/j.wneu.2017.08.133 28867321
    [Google Scholar]
  17. Halazonetis TD Gorgoulis VG Bartek J An oncogene-induced DNA damage model for cancer development. Science 2008 319 5868 1352 1355
    [Google Scholar]
  18. Collisson E.A. Cho R.J. Gray J.W. What are we learning from the cancer genome? Nat. Rev. Clin. Oncol. 2012 9 11 621 630 10.1038/nrclinonc.2012.159 22965149
    [Google Scholar]
  19. Das S.K. Menezes M.E. Bhatia S. Wang X.Y. Emdad L. Sarkar D. Fisher P.B. Gene therapies for cancer: Strategies, challenges and successes. J. Cell. Physiol. 2015 230 2 259 271 10.1002/jcp.24791 25196387
    [Google Scholar]
  20. Pérez M.L. Culver S. Owen J.L. Dunbar M. Kow K. Breen M. Milner R.J. Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia. Anticancer Drugs 2013 24 10 1098 1103 10.1097/CAD.0000000000000018 23995854
    [Google Scholar]
  21. Keller R.L. Avery A.C. Burnett R.C. Walton J.A. Olver C.S. Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement. Vet. Clin. Pathol. 2004 33 3 145 149 10.1111/j.1939‑165X.2004.tb00364.x 15334349
    [Google Scholar]
  22. Thalheim L. Williams L.E. Borst L.B. Fogle J.E. Suter S.E. Lymphoma immunophenotype of dogs determined by immunohistochemistry, flow cytometry, and polymerase chain reaction for antigen receptor rearrangements. J. Vet. Intern. Med. 2013 27 6 1509 1516 10.1111/jvim.12185 24112291
    [Google Scholar]
  23. Moore P.F. Woo J.C. Vernau W. Kosten S. Graham P.S. Characterization of feline T cell receptor gamma (TCRG) variable region genes for the molecular diagnosis of feline intestinal T cell lymphoma. Vet. Immunol. Immunopathol. 2005 106 3-4 167 178 10.1016/j.vetimm.2005.02.014 15963816
    [Google Scholar]
  24. Burnett R.C. Vernau W. Modiano J.F. Olver C.S. Moore P.F. Avery A.C. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet. Pathol. 2003 40 1 32 41 10.1354/vp.40‑1‑32 12627711
    [Google Scholar]
  25. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004 4 7 540 550 10.1038/nrc1388 15229479
    [Google Scholar]
  26. Valli V.E. Kass P.H. Myint M.S. Scott F. Canine Lymphomas. Vet. Pathol. 2013 50 5 738 748 10.1177/0300985813478210 23444036
    [Google Scholar]
  27. Henry C.J. Tyler J.W. McEntee M.C. Stokol T. Rogers K.S. Chun R. Garrett L.D. McCaw D.L. Higginbotham M.L. Flessland K.A. Stokes P.K. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Am. J. Vet. Res. 2003 64 8 1017 1020 10.2460/ajvr.2003.64.1017 12926595
    [Google Scholar]
  28. Vinall R.L. Kent M.S. White D.R.W. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Am. J. Vet. Res. 2012 73 10 1626 1633 10.2460/ajvr.73.10.1626 23013190
    [Google Scholar]
  29. Shapiro S.G. Knapp D.W. Breen M. A cultured approach to canine urothelial carcinoma: Molecular characterization of five cell lines. Canine Genet. Epidemiol. 2015 2 1 15 10.1186/s40575‑015‑0028‑3 26401343
    [Google Scholar]
  30. Zijl V.F. Krupitza G. Mikulits W. Initial steps of metastasis: Cell invasion and endothelial transmigration. Mutat. Res. Rev. Mutat. Res. 2011 728 1-2 23 34 10.1016/j.mrrev.2011.05.002 21605699
    [Google Scholar]
  31. Goldfarb R.H. Liotta L.A. Proteolytic enzymes in cancer invasion and metastasis. Semin. Thromb. Hemost. 1986 12 4 294 307 10.1055/s‑2007‑1003570
    [Google Scholar]
  32. Lynch C.C. Matrisian L.M. Matrix metalloproteinases in tumor–host cell communication. Differentiation 2002 70 9-10 561 573 10.1046/j.1432‑0436.2002.700909.x 12492497
    [Google Scholar]
  33. Mareel M. Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 2003 83 2 337 376 10.1152/physrev.00024.2002 12663862
    [Google Scholar]
  34. Akerele O. Medicinal plants and primary health care: An agenda for action. East. Mediter. Reg. Drugs Digest. 1991 8 2 11 25
    [Google Scholar]
  35. Legal status of traditional medicine and complementary. Geneva, Switzerland World Health Organization 2001 1 6
    [Google Scholar]
  36. Gralow J. Ozols R.F. Bajorin D.F. Cheson B.D. Sandler H.M. Winer E.P. Bonner J. Demetri G.D. Curran W. Jr Ganz P.A. Kramer B.S. Kris M.G. Markman M. Mayer R.J. Raghavan D. Ramsey S. Reaman G.H. Sawaya R. Schuchter L.M. Sweetenham J.W. Vahdat L.T. Davidson N.E. Schilsky R.L. Lichter A.S. Clinical cancer advances 2007: Major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J. Clin. Oncol. 2008 26 2 313 325 10.1200/JCO.2007.15.4088 18086794
    [Google Scholar]
  37. Kintzios S.E. Terrestrial plant-derived anticancer agents and plant species used in anticancer research. Crit. Rev. Plant Sci. 2006 25 2 79 113 10.1080/07352680500348824
    [Google Scholar]
  38. Newman V. Rock C.L. Faerber S. Flatt S.W. Wright F.A. Pierce J.P. Dietary supplement use by women at risk for breast cancer recurrence. J. Am. Diet. Assoc. 1998 98 3 285 292 10.1016/S0002‑8223(98)00068‑6 9508010
    [Google Scholar]
  39. Sawyer M.G. Gannoni A.F. Toogood I.R. Antoniou G. Rice M. The use of alternative therapies by children with cancer. Med. J. Aust. 1994 160 6 320 322 10.5694/j.1326‑5377.1994.tb138228.x 8133811
    [Google Scholar]
  40. Burstein H.J. Gelber S. Guadagnoli E. Weeks J.C. Use of alternative medicine by women with early-stage breast cancer. N. Engl. J. Med. 1999 340 22 1733 1739 10.1056/NEJM199906033402206 10352166
    [Google Scholar]
  41. Gurley B.J. Gardner S.F. Hubbard M.A. Content versus label claims in ephedra-containing dietary supplements. Am. J. Health Syst. Pharm. 2000 57 10 963 969 10.1093/ajhp/57.10.963 10832496
    [Google Scholar]
  42. Islam M.R. Islam F. Nafady M.H. Akter M. Mitra S. Das R. Urmee H. Shohag S. Akter A. Chidambaram K. Alhumaydhi F.A. Emran T.B. Cavalu S. Natural small molecules in breast cancer treatment: Understandings from a therapeutic viewpoint. Molecules 2022 27 7 2165 10.3390/molecules27072165 35408561
    [Google Scholar]
  43. Fan Y. Ma Z. Zhao L. Wang W. Gao M. Jia X. Ouyang H. He J. Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review. Biomed. Pharmacother. 2020 132 110820 10.1016/j.biopha.2020.110820 33035836
    [Google Scholar]
  44. Pérez-Escalante E. Cariño-Cortés R. Fernández-Martínez E. Ortiz M.I. Muñoz-Pérez V.M. Sánchez-Crisóstomo I. Jiménez-Ángeles L. Colorectal cancer: Causes and evidence of chemopreventive treatments. Curr. Pharm. Biotechnol. 2019 19 14 1135 1155 10.2174/1389201020666181226112712 30585544
    [Google Scholar]
  45. Grammatikopoulou M.G. Gkiouras K. Papageorgiou S.Τ. Myrogiannis I. Mykoniatis I. Papamitsou T. Bogdanos D.P. Goulis D.G. Dietary factors and supplements influencing prostate-specific antigen (PSA) concentrations in men with prostate cancer and increased cancer risk: An evidence analysis review based on randomized controlled trials. Nutrients 2020 12 10 2985 10.3390/nu12102985 33003518
    [Google Scholar]
  46. Chinembiri T. Plessis D.L. Gerber M. Hamman J. Plessis D.J. Review of natural compounds for potential skin cancer treatment. Molecules 2014 19 8 11679 11721 10.3390/molecules190811679 25102117
    [Google Scholar]
  47. Kang Y. Park C. Lee H. Kang S. Cheon C. Kim B. Natural products as new approaches for treating bladder cancer: From traditional medicine to novel drug discovery. Pharmaceutics 2023 15 4 1117 10.3390/pharmaceutics15041117 37111603
    [Google Scholar]
  48. Stoff J.A. A multimodal strategic approach to integrative oncology. Asian J. Immunology. 2022 6 1 1 39
    [Google Scholar]
  49. Ryduchowski D. Help nature to heal you from cancer: A guide on cancer prevention, and natural and alternative therapies. Available from: https://www.amazon.com.au/HELP-NATURE-HEAL-YOU-CANCER/dp/0595387055
  50. Djamgoz M.B.A. Jentzsch V. Integrative management of pancreatic cancer (PDAC): Emerging complementary agents and modalities. Nutr. Cancer 2022 74 4 1139 1162 10.1080/01635581.2021.1934043 34085871
    [Google Scholar]
  51. Mohapatra S. Kumar P.A. Aggarwal A. Iqubal A. Mirza M.A. Iqbal Z. Phytotherapeutic approach for conquering menopausal syndrome and osteoporosis. Phytother. Res. 2024 38 6 2728 2763 10.1002/ptr.8172 38522005
    [Google Scholar]
  52. Alamgir A.N. Alamgir A.N. Biotechnology, in vitro production of natural bioactive compounds, herbal preparation, and disease management (treatment and prevention). Therapeutic Use of Medicinal Plants and their Extracts. Cham Springer 2018 2 585 664
    [Google Scholar]
  53. Singh B. Sundar S. Shukla A. Herbal Medicines for Thyroid Diseases. InTreating Endocrine and Metabolic Disorders with Herbal Medicines. Hershey, Pennsylvania, USA IGI Global 2021 256 277 10.4018/978‑1‑7998‑4808‑0.ch011
    [Google Scholar]
  54. Shreya S. In-silico approaches of polyphenols and in-vivo evaluation of neuroprotective effects of eugenia jambolana leaves extract for anticholinesterase and antioxidant activities. Doctoral Thesis, Dissertation, Karpagam College of Pharmacy, Coimbatore 2014
    [Google Scholar]
  55. Pereira G Vinoo S Yadhav P Multiple gastrointestinal tract disorders. Nutraceuticals: A Holistic Approach to Disease Prevention Berlin Boston: De Gruyter 2024 193 222
    [Google Scholar]
  56. Berman J. Joel Berman's Integrative Guide to Prevention and Treatment. Nashville, Tennessee Turner Publishing Company 2013
    [Google Scholar]
  57. Baker V.L. Leitman D. Jaffe R.B. Selective estrogen receptor modulators in reproductive medicine and biology. Obstet. Gynecol. Surv. 2000 55 7 Suppl. 2 S21 S47 10.1097/00006254‑200007001‑00001 10890575
    [Google Scholar]
  58. Deep A. Kumar D. Bansal N. Narasimhan B. Marwaha R.K. Sharma P.C. Understanding mechanistic aspects and therapeutic potential of natural substances as anticancer agents. Phytomed. Plus 2023 3 2 100418 10.1016/j.phyplu.2023.100418
    [Google Scholar]
  59. Schar D. Grifola frondosa and the human immuno-deficiency virus. Brit. J. Phytoth. 1998 5 13 22
    [Google Scholar]
  60. Yance D Valentine A. Herbal medicine, healing & cancer. 1999 Available from: https://www.amazon.com/Herbal-Medicine-Healing-Cancer-Comprehensive/dp/0879839686
  61. Fang D.C. Jass J.R. Wang D.X. Zhou X.D. Luo Y.H. Young J. Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancer showing DNA microsatellite instability. J. Clin. Pathol. 1999 52 7 504 508 10.1136/jcp.52.7.504 10605402
    [Google Scholar]
  62. Chen J.K. Chen T.T. Crampton L. Chinese medical herbology and pharmacology. City of Industry, CA Art of Medicine Press 2004
    [Google Scholar]
  63. Yoshida Y. Wang M.Q. Liu J.N. Shan B.E. Yamashita U. Immunomodulating activity of chinese medicinal herbs and Oldenlandia diffusa in particular. Int. J. Immunopharmacol. 1997 19 7 359 370 10.1016/S0192‑0561(97)00076‑3 9568540
    [Google Scholar]
  64. Yance D Valentine A. Herbal medicine, healing & cancer. 1999 Available from: https://www.amazon.com/Herbal-Medicine-Healing-Cancer-Comprehensive/dp/0879839686
    [Google Scholar]
  65. Ghoneum M. Wimbley M. Salem F. McKlain A. Attallah N. Gill G. Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC). Int. J. Immunother. 1995 11 1 23 28
    [Google Scholar]
  66. Leak J.A. Herbal medicine: Is it an alternative or an unknown? A brief review of popular herbals used by patients in a pain and symptom management practice setting. Curr. Rev. Pain 1999 3 3 226 236 10.1007/s11916‑999‑0017‑x 10998678
    [Google Scholar]
  67. Stavropoulos N.E. Kim A. Nseyo U.U. Tsimaris I. Chung T.D. Miller T.A. Redlak M. Nseyo U.O. Skalkos D. Hypericum perforatum L. extract – Novel photosensitizer against human bladder cancer cells. J. Photochem. Photobiol. B 2006 84 1 64 69 10.1016/j.jphotobiol.2006.02.001 16540336
    [Google Scholar]
  68. Hatcher H. Planalp R. Cho J. Torti F.M. Torti S.V. Curcumin: From ancient medicine to current clinical trials. Cell. Mol. Life Sci. 2008 65 11 1631 1652 10.1007/s00018‑008‑7452‑4 18324353
    [Google Scholar]
  69. Hoimes C.J. Strimpakos A.S. Saif M.W. Therapeutic tools in pancreatic cancer. JOP 2009 10 2 118 122 19287103
    [Google Scholar]
  70. Riggs D.R. DeHaven J.I. Lamm D.L. Allium sativum (garlic) treatment for murine transitional cell carcinoma. Cancer 1997 79 10 1987 1994 10.1002/(SICI)1097‑0142(19970515)79:10<1987::AID‑CNCR21>3.0.CO;2‑Q 9149027
    [Google Scholar]
  71. WHO monographs on selected medicinal plants. Geneva, Switzerland World Health Organization 1999 1 9
    [Google Scholar]
  72. Xu A.H. Chen H.S. Sun B.C. Xiang X.R. Chu Y.F. Zhai F. Jia L.C. Therapeutic mechanism of ginkgo biloba exocarp polysaccharides on gastric cancer. World J. Gastroenterol. 2003 9 11 2424 2427 10.3748/wjg.v9.i11.2424 14606069
    [Google Scholar]
  73. Wickremesinhe E.R.M. Arteea R.N. Taxus callus cultures: Initiation, growth optimization, characterization and taxol production. Plant Cell Tissue Organ Cult. 1993 35 2 181 193 10.1007/BF00032968
    [Google Scholar]
  74. Wickremesinhe E.R.M. Arteca R.N. Taxus cell suspension cultures: Optimizing growth and production of taxol. J. Plant Physiol. 1994 144 2 183 188 10.1016/S0176‑1617(11)80541‑9
    [Google Scholar]
  75. Cragg G.M. Schepartz S.A. Suffness M. Grever M.R. The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J. Nat. Prod. 1993 56 10 1657 1668 10.1021/np50100a001 7903979
    [Google Scholar]
  76. Sharma N. Trikha P. Athar M. Raisuddin S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem. Toxicol. 2000 23 3 477 484 10.1081/DCT‑100100129 10959548
    [Google Scholar]
  77. Bin-Hafeez B. Ahmad I. Haque R. Raisuddin S. Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice. J. Ethnopharmacol. 2001 75 1 13 18 10.1016/S0378‑8741(00)00382‑2 11282437
    [Google Scholar]
  78. Brown R.P. Gerbarg P.L. Ramazanov Z. Rhodiola rosea. A phytomedicinal overview. HerbalGram 2002 56 40 52
    [Google Scholar]
  79. Shukla S. Mehta A. Anticancer potential of medicinal plants and their phytochemicals: A review. Rev. Bras. Bot. 2015 38 2 199 210 10.1007/s40415‑015‑0135‑0
    [Google Scholar]
  80. Andre C. Larondelle Y. Evers D. Dietary antioxidants and oxidative stress from a human and plant perspective: A review. Curr. Nutr. Food Sci. 2010 6 1 2 12 10.2174/157340110790909563
    [Google Scholar]
  81. Gupta S.C. Patchva S. Aggarwal B.B. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J. 2013 15 1 195 218 10.1208/s12248‑012‑9432‑8 23143785
    [Google Scholar]
  82. Wilken R. Veena M.S. Wang M.B. Srivatsan E.S. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 2011 10 1 12 10.1186/1476‑4598‑10‑12 21299897
    [Google Scholar]
  83. Athar M. Back J. Tang X. Kim K. Kopelovich L. Bickers D. Kim A. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007 224 3 274 283 10.1016/j.taap.2006.12.025 17306316
    [Google Scholar]
  84. Anastas J.N. Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013 13 1 11 26 10.1038/nrc3419 23258168
    [Google Scholar]
  85. Hosseini A. Ghorbani A. Cancer therapy with phytochemicals: Evidence from clinical studies. Avicenna J. Phytomed. 2015 5 2 84 97 25949949
    [Google Scholar]
  86. Hamilton-Miller J.M.T. Anti-cariogenic properties of tea (Camellia sinensis). J. Med. Microbiol. 2001 50 4 299 302 10.1099/0022‑1317‑50‑4‑299 11289514
    [Google Scholar]
  87. Powolny A.A. Singh S.V. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett. 2008 269 2 305 314 10.1016/j.canlet.2008.05.027 18579286
    [Google Scholar]
  88. Ramakrishnan R. Anticancer properties of Zingiber officinale–Ginger: A review. Int. J. Med. Pharm. Sci. 2013 3 5 11 20
    [Google Scholar]
  89. Li C. Cai J. Geng J. Li Y. Wang Z. Li R. Purification, characterization and anticancer activity of a polysaccharide from Panax ginseng. Int. J. Biol. Macromol. 2012 51 5 968 973 10.1016/j.ijbiomac.2012.06.031 22750577
    [Google Scholar]
  90. Patel S Goyal A Recent developments in mushrooms as anti-cancer therapeutics: A review. 3 Biotech 2012 2 1 5
    [Google Scholar]
  91. Rai M. Jogee P.S. Agarkar G. Santos C.A. Anticancer activities of Withania somnifera : Current research, formulations, and future perspectives. Pharm. Biol. 2016 54 2 189 197 10.3109/13880209.2015.1027778 25845640
    [Google Scholar]
  92. Noble R.L. The discovery of the vinca alkaloids—chemotherapeutic agents against cancer. Biochem. Cell Biol. 1990 68 12 1344 1351 10.1139/o90‑197 2085431
    [Google Scholar]
  93. Jordan M.A. Thrower D. Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 1991 51 8 2212 2222 2009540
    [Google Scholar]
  94. Krishan A. Paika K. Frei E. III Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. J. Cell Biol. 1975 66 3 521 530 10.1083/jcb.66.3.521 1057547
    [Google Scholar]
  95. George B.P. Chandran R. Abrahamse H. Role of phytochemicals in cancer chemoprevention: Insights. Antioxidants 2021 10 9 1455 10.3390/antiox10091455 34573087
    [Google Scholar]
  96. Dave A. Parande F. Park E.J. Pezzuto J.M. Phytochemicals and cancer chemoprevention. J. Cancer Metastasis Treat. 2020 6 46
    [Google Scholar]
  97. Atiq A. Parhar I. Anti-neoplastic potential of flavonoids and polysaccharide phytochemicals in glioblastoma. Molecules 2020 25 21 4895 10.3390/molecules25214895 33113890
    [Google Scholar]
  98. Singh R. Agarwal R. Tumor angiogenesis: A potential target in cancer control by phytochemicals. Curr. Cancer Drug Targets 2003 3 3 205 217 10.2174/1568009033481985 12769689
    [Google Scholar]
  99. Abbaoui B. Lucas C.R. Riedl K.M. Clinton S.K. Mortazavi A. Cruciferous vegetables, isothiocyanates, and bladder cancer prevention. Mol. Nutr. Food Res. 2018 62 18 1800079 10.1002/mnfr.201800079 30079608
    [Google Scholar]
  100. Engwa G.A. Free radicals and the role of plant phytochemicals as antioxidants against oxidative stress-related diseases. Phytochemicals: Source of antioxidants and role in disease prevention. BoD Books Dem. 2018 7 49 74
    [Google Scholar]
  101. Peng Y. Ao M. Dong B. Jiang Y. Yu L. Chen Z. Hu C. Xu R. Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Des. Devel. Ther. 2021 15 4503 4525 10.2147/DDDT.S327378 34754179
    [Google Scholar]
  102. Kubczak M. Szustka A. Rogalińska M. Molecular targets of natural compounds with anti-cancer properties. Int. J. Mol. Sci. 2021 22 24 13659 10.3390/ijms222413659 34948455
    [Google Scholar]
  103. Chaichian S. Moazzami B. Sadoughi F. Kashani H.H. Zaroudi M. Asemi Z. Functional activities of beta-glucans in the prevention or treatment of cervical cancer. J. Ovarian Res. 2020 13 1 24 10.1186/s13048‑020‑00626‑7 32138756
    [Google Scholar]
  104. Morbidelli L. Polyphenol-based nutraceuticals for the control of angiogenesis: Analysis of the critical issues for human use. Pharmacol. Res. 2016 111 384 393 10.1016/j.phrs.2016.07.011 27402192
    [Google Scholar]
  105. Razis A.A.F. Konsue N. Ioannides C. Isothiocyanates and xenobiotic detoxification. Mol. Nutr. Food Res. 2018 62 18 1700916 10.1002/mnfr.201700916 29288567
    [Google Scholar]
  106. Carvalho A.A. Costa P.M. Vieira G.C. Jamacaru F.V. Moraes M.O. Cavalcanti B.C. Pessoa C. Natural products used as candidates for angiogenesis inhibitors in cancer therapy. Trends Org. Chem. 2011 15 79 93
    [Google Scholar]
  107. Dorrell M.I. Aguilar E. Scheppke L. Barnett F.H. Friedlander M. Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis. Proc. Natl. Acad. Sci. USA 2007 104 3 967 972 10.1073/pnas.0607542104 17210921
    [Google Scholar]
  108. Rudzińska A. Juchaniuk P. Oberda J. Wiśniewska J. Wojdan W. Szklener K. Mańdziuk S. Phytochemicals in cancer treatment and cancer prevention—review on epidemiological data and clinical trials. Nutrients 2023 15 8 1896 10.3390/nu15081896 37111115
    [Google Scholar]
  109. Majrashi T.A. Alshehri S.A. Alsayari A. Muhsinah A.B. Alrouji M. Alshahrani A.M. Shamsi A. Atiya A. Insight into the biological roles and mechanisms of phytochemicals in different types of cancer: Targeting cancer therapeutics. Nutrients 2023 15 7 1704 10.3390/nu15071704 37049544
    [Google Scholar]
  110. Ludwiczuk A. Najda A. Wolski T. Baj T. Chromatographic determination of the content and the composition of extracts and essential oils from the fruits of three varieties of stalk celery (Apium graveolens L. var. dulce Mill. Pers.). JPC J. Plan. Chromat. Mod. TLC. 2001 14 6 400 404
    [Google Scholar]
  111. Gupta S.C. Patchva S. Koh W. Aggarwal B.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 2012 39 3 283 299 10.1111/j.1440‑1681.2011.05648.x 22118895
    [Google Scholar]
  112. Martinez R.M. Pinho-Ribeiro F.A. Steffen V.S. Silva T.C.C. Caviglione C.V. Bottura C. Fonseca M.J.V. Vicentini F.T.M.C. Vignoli J.A. Baracat M.M. Georgetti S.R. Verri W.A. Jr Casagrande R. Topical formulation containing naringenin: Efficacy against ultraviolet B irradiation-induced skin inflammation and oxidative stress in mice. PLoS One 2016 11 1 e0146296 10.1371/journal.pone.0146296 26741806
    [Google Scholar]
  113. Surh Y.J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem. Toxicol. 2002 40 8 1091 1097 10.1016/S0278‑6915(02)00037‑6 12067569
    [Google Scholar]
  114. Najda A. Błaszczyk L. Winiarczyk K. Dyduch J. Tchórzewska D. Comparative studies of nutritional and health-enhancing properties in the “garlic-like” plant Allium ampeloprasum var. Sci. Hortic. 2016 201 247 255 10.1016/j.scienta.2016.01.044
    [Google Scholar]
  115. Yesil-Celiktas O. Sevimli C. Bedir E. Vardar-Sukan F. Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum. Nutr. 2010 65 2 158 163 10.1007/s11130‑010‑0166‑4 20449663
    [Google Scholar]
  116. Kwon H.J. Shim J.S. Kim J.H. Cho H.Y. Yum Y.N. Kim S.H. Yu J. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn. J. Cancer Res. 2002 93 4 417 425 10.1111/j.1349‑7006.2002.tb01273.x 11985792
    [Google Scholar]
  117. Shimamura M. Hazato T. Ashino H. Yamamoto Y. Iwasaki E. Tobe H. Yamamoto K. Yamamoto S. Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochem. Biophys. Res. Commun. 2001 289 1 220 224 10.1006/bbrc.2001.5934 11708802
    [Google Scholar]
  118. Shukla Y. Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann. N. Y. Acad. Sci. 2011 1215 1 1 8 10.1111/j.1749‑6632.2010.05870.x 21261635
    [Google Scholar]
  119. Höper M.M. Voelkel N.F. Bates T.O. Allard J.D. Horan M. Shepherd D. Tuder R.M. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am. J. Respir. Cell Mol. Biol. 1997 17 6 748 756 10.1165/ajrcmb.17.6.2888 9409562
    [Google Scholar]
  120. Romano M. Clària J. Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy. FASEB J. 2003 17 14 1986 1995 10.1096/fj.03‑0053rev 14597668
    [Google Scholar]
  121. Schempp C.M. Kirkin V. Simon-Haarhaus B. Kersten A. Kiss J. Termeer C.C. Gilb B. Kaufmann T. Borner C. Sleeman J.P. Simon J.C. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John’s wort that acts by induction of apoptosis. Oncogene 2002 21 8 1242 1250 10.1038/sj.onc.1205190 11850844
    [Google Scholar]
  122. Donà M. Dell’Aica I. Pezzato E. Sartor L. Calabrese F. Barbera M.D. Donella-Deana A. Appendino G. Borsarini A. Caniato R. Garbisa S. Hyperforin inhibits cancer invasion and metastasis. Cancer Res. 2004 64 17 6225 6232 10.1158/0008‑5472.CAN‑04‑0280 15342408
    [Google Scholar]
  123. Martínez-Poveda B. Quesada A.R. Medina M.Á. Hyperforin, a bio‐active compound of St. John’s Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int. J. Cancer 2005 117 5 775 780 10.1002/ijc.21246 15981212
    [Google Scholar]
  124. Roy S. Khanna S. Alessio H.M. Vider J. Bagchi D. Bagchi M. Sen C.K. Anti-angiogenic property of edible berries. Free Radic. Res. 2002 36 9 1023 1032 10.1080/1071576021000006662 12448828
    [Google Scholar]
  125. Teicher B.A. Newer cytotoxic agents: Attacking cancer broadly. Clin. Cancer Res. 2008 14 6 1610 1617 10.1158/1078‑0432.CCR‑07‑2249 18347161
    [Google Scholar]
  126. Katz L. Baltz R.H. Natural product discovery: Past, present, and future. J. Ind. Microbiol. Biotechnol. 2016 43 2-3 155 176 10.1007/s10295‑015‑1723‑5 26739136
    [Google Scholar]
  127. Zalega J. Szostak-Węgierek D. Nutrition in cancer prevention. part I. Plant polyphenols, carotenoids, dietary fiber. Probl Hig Epidemiol. 2013 94 1 41 49
    [Google Scholar]
  128. Vapiwala N. Mick R. Hampshire M.K. Metz J.M. DeNittis A.S. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006 12 6 467 474 10.1097/00130404‑200611000‑00006 17207316
    [Google Scholar]
  129. Williamson E.M. Interactions between herbal and conventional medicines. Expert Opin. Drug Saf. 2005 4 2 355 378 10.1517/14740338.4.2.355 15794726
    [Google Scholar]
  130. Wang Y. Fan X. Qu H. Gao X. Cheng Y. Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Curr. Top. Med. Chem. 2012 12 12 1356 1362 10.2174/156802612801319034 22690682
    [Google Scholar]
  131. Abdulridha M.K. Al-Marzoqi A.H. Al-awsi G.R.L. Mubarak S.M.H. Heidarifard M. Ghasemian A. Anticancer effects of herbal medicine compounds and novel formulations: A literature review. J. Gastrointest. Cancer 2020 51 3 765 773 10.1007/s12029‑020‑00385‑0 32140897
    [Google Scholar]
  132. Younes M. Mardirossian R. Rizk L. Fazlian T. Khairallah J.P. Sleiman C. Naim H.Y. Rizk S. The synergistic effects of curcumin and chemotherapeutic drugs in inhibiting metastatic, invasive and proliferative pathways. Plants 2022 11 16 2137 10.3390/plants11162137 36015440
    [Google Scholar]
  133. Abdelrahman I. El-Kashef H. Hassan N. Anti-tumor effect of green tea extract, simvastatin and gamma radiation on solid tumor in mice. Arab J. Nucl. Sci. Appl. 2020 0 0 1 14 10.21608/ajnsa.2020.22827.1322
    [Google Scholar]
  134. Lucius K. Hill J. Combining immunotherapy and natural immune stimulants: Mechanisms and clinical implications. J. Cancer Res. Clin. Oncol. 2019 145 10 2633 2635 10.1007/s00432‑018‑02830‑x 30673870
    [Google Scholar]
  135. Seo E.J. Klauck S.M. Efferth T. Panossian A. Adaptogens in chemobrain (Part II): Effect of plant extracts on chemotherapy-induced cytotoxicity in neuroglia cells. Phytomedicine 2019 58 152743 10.1016/j.phymed.2018.11.004 30901664
    [Google Scholar]
  136. Yasueda A. Urushima H. Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: A systematic review. Integr. Cancer Ther. 2016 15 1 17 39 10.1177/1534735415610427 26503419
    [Google Scholar]
  137. Tascilar M. Jong D.F.A. Verweij J. Mathijssen R.H.J. Complementary and alternative medicine during cancer treatment: Beyond innocence. Oncologist 2006 11 7 732 741 10.1634/theoncologist.11‑7‑732 16880232
    [Google Scholar]
  138. Bhatt V. Dey S. Interactions between herbal remedies and conventional drugs in cancer therapy: Mechanistic insights and clinical implications. J. Complement. Integr. Med. 2020 4 1 12
    [Google Scholar]
  139. Patel K. Gadewar M. Tripathi N. Adverse effects of herbal medicine in oncology: A comprehensive review. Curr. Pharm. Biotechnol. 2021 6 765 774
    [Google Scholar]
  140. Stournaras E. Tziomalos K. Herbal medicine-related hepatotoxicity. World J. Hepatol. 2015 7 19 2189 2193 10.4254/wjh.v7.i19.2189 26380043
    [Google Scholar]
  141. Zhang A. Sun H. Wang X. Herb-induced toxicities and adverse drug reactions in cancer treatment. Curr. Drug Metab. 2018 19 4 317 328
    [Google Scholar]
  142. Shi J. Liu Y. Zhang Z. Antioxidant herbs in cancer therapy: Mechanisms, benefits, and risks. Antioxidants 2022 11 5 890 905 35624754
    [Google Scholar]
  143. Ahmad I. Aqil F. Owais M. Modern Phytomedicine: Turning Medicinal Plants into Drugs. Hoboken, New Jersey Wiley 2006 10.1002/9783527609987
    [Google Scholar]
  144. World Health Organization. Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva, 1996 1 3 Available from: https://www.who.int/docs/default-source/medicines/norms-andstandards/guidelines/quality-control/quality-control-methods-formedicinal-plant-materials.pdf?sfvrsn=b451e7c6_0">
  145. Bauer R. Quality criteria and standardization of phytopharmaceuticals: Can acceptable drug standards be achieved? Drug Inf. J. 1998 32 1 101 110 10.1177/009286159803200114
    [Google Scholar]
  146. Jiang J.G. Yang H.L. Quality control and standardization of ginseng products. Phytochem. Anal. 2015 26 4 343 349
    [Google Scholar]
  147. Zhang H. Xu Y. Combination of herbal medicines in cancer treatment: Traditional and modern perspectives. J. Ethnopharmacol. 2019 249 112397
    [Google Scholar]
  148. Cheon C. Ko S.G. A phase I study to evaluate the safety of the herbal medicine SH003 in patients with solid cancer. Integr. Cancer Ther. 2020 19 1534735420911442 10.1177/1534735420911442 32186413
    [Google Scholar]
  149. Terkola R. Bardin C. Cundin L.G. Zeinab N. Crul M. Identifying options for oncology therapy regimen codification to improve standardization—combined results of an expert panel and a review. J. Clin. Pharm. Ther. 2021 46 5 1238 1244 10.1111/jcpt.13402 33687085
    [Google Scholar]
  150. Berretta M. Lago D.L. Tinazzi M. Ronchi A. Rocca L.G. Montella L. Francia D.R. Facchini B.A. Bignucolo A. Montopoli M. Evaluation of concomitant use of anticancer drugs and herbal products: From interactions to synergic activity. Cancers 2022 14 21 5203 10.3390/cancers14215203 36358622
    [Google Scholar]
  151. Meijerman I. Beijnen J.H. Schellens J.H.M. Herb-drug interactions in oncology: Focus on mechanisms of induction. Oncologist 2006 11 7 742 752 10.1634/theoncologist.11‑7‑742 16880233
    [Google Scholar]
  152. Singh J. Luqman S. Meena A. Emerging role of phytochemicals in targeting predictive, prognostic, and diagnostic biomarkers of lung cancer. Food Chem. Toxicol. 2020 144 111592 10.1016/j.fct.2020.111592 32702507
    [Google Scholar]
  153. Efferth T. Saeed M.E.M. Mirghani E. Alim A. Yassin Z. Saeed E. Khalid H.E. Daak S. Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget 2017 8 30 50284 50304 10.18632/oncotarget.17466 28514737
    [Google Scholar]
/content/journals/cctr/10.2174/0115733947366002250409170920
Loading
Phytochemicals in Cancer Therapy: Unleashing the Healing Power of Herbs
Bentham Science Publishers ; https://doi.org/10.2174/0115733947366002250409170920
/content/journals/cctr/10.2174/0115733947366002250409170920
/content/journals/cctr/10.2174/0115733947366002250409170920
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: anticancer ; DNA ; phytochemicals ; herbal medicine ; herbal remedies ; cells ; Cancer

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test